Coagulation and Fibrinolysis Abnormalities in the Acute Stage of Hypertensive Intracerebral Hemorrhage, with Special Reference to Fibrinopeptides A and Bβ15-42

Coagulation studies were performed in 11 patients in the acute stage of hypertensive intracerebral hemorrhage. The items tested include platelet count, prothrombin time, partial thromboplastin time, fibrinogen, antithrombin III, fibrin/fibrinogen degradation products, α2 macroglobulin, α2 plasmin inhibitor, fibrinopeptide A (FPA), and fibrinopeptide Bβ15-42 (FPBβ). Blood was collected from peripheral veins within 6 hours and again between the 7th and 14th days after the onset of symptoms. Disseminated intravascular coagulation (DIC) occurred in one patient, in whom the tests were repeated several times for 14 days. Fibrinopeptide levels were extremely high within 6 hours after the onset of symptoms and normalized between the 7th and 14th days. Fibrinopeptides were especially high in the patient with DIC, which was caused by primary brain damage. Normal FPA levels were restored sooner than those of the other substances after administration of heparin and gabexate mesilate. It appears that damage to cerebral tissue occasionally brings about DIC and that FPA and FPBβ may be excellent indices for predicting coagulation and fibrinolytic imbalance and for managing DIC.

[1]  H. Kwaan Disseminated intravascular coagulation. , 2019, The Medical clinics of North America.

[2]  P. Gildenberg,et al.  Clinicopathological correlations of disseminated intravascular coagulation in patients with head injury. , 1984, Neurosurgery.

[3]  A. Spallone,et al.  Disseminated intravascular coagulation as a complication of ruptured intracranial aneurysms. Report of two cases. , 1983, Journal of neurosurgery.

[4]  M. Blombäck,et al.  Measurement in human blood of fibrinogen/fibrin fragments containing the bβ 15–42 sequence , 1982 .

[5]  I. Maruyama,et al.  [Disseminated intravascular coagulation (DIC); findings in 40 patients (author's transl)]. , 1981, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[6]  J. V. van Mourik,et al.  Significance of plasma fibrinopeptide A (fpA) in patients with malignancy. , 1980, The Journal of laboratory and clinical medicine.

[7]  J. Lewis,et al.  Disseminated Intravascular Coagulation , 1980, Thrombosis and Haemostasis.

[8]  M. Netsky,et al.  Disseminated intravascular coagulation following cranial trauma. Case report. , 1980, Journal of neurosurgery.

[9]  J. Van Der Sande,et al.  Head injury and coagulation disorders. , 1978, Journal of neurosurgery.

[10]  T. Astrup,et al.  Localization of fibrinolytic activity and inhibition of plasmin in the spinal cord of rat, guinea pig, and rabbit. , 1978, Journal of neurosurgery.

[11]  A. Teger‐Nilsson,et al.  Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. , 1977, Scandinavian journal of clinical and laboratory investigation.

[12]  A. Sharp Diagnosis and management of disseminated intravascular coagulation. , 1977, British medical bulletin.

[13]  Ducker Tb,et al.  Disseminated intravascular coagulation associated with removal of a primary brain tumor. Case report. , 1977 .

[14]  C. Vecht,et al.  Disseminated intravascular coagulation and head injury. , 1975, Lancet.

[15]  O. Odegård,et al.  Heparin cofactor activity measured with an amidolytic method. , 1975, Thrombosis research.

[16]  Y. Vardi,et al.  Diffuse intravascular clotting associated with a primary brain tumour , 1974 .

[17]  J. Woods,et al.  Effect of surgical operations on certain tests used to diagnose intravascular coagulation and fibrinolysis. , 1974, Mayo Clinic proceedings.

[18]  F. Preston,et al.  Disseminated intravascular coagulation as a consequence of cerebral damage , 1974, Journal of neurology, neurosurgery, and psychiatry.

[19]  D. Tovi,et al.  FIBRINOLYTIC ACTIVITY OF HUMAN BRAIN. A HISTOCHEMICAL STUDY , 1973, Acta neurologica Scandinavica.

[20]  L. Harker,et al.  Platelet and fibrinogen consumption in man. , 1972, The New England journal of medicine.

[21]  Garvey Mb,et al.  The detection of fibrinogen/fibrin degradation products by means of a new antibody-coated latex particle , 1972, Journal of clinical pathology.

[22]  R. Colman,et al.  Disseminated intravascular coagulation (DIC): an approach. , 1972, The American journal of medicine.

[23]  M. Ettinger Coagulation Abnormalities in Subarachnoid Hemorrhage , 1970, Stroke.

[24]  S. Takashima,et al.  Fibrinolytic activity of human brain and cerebrospinal fluid. , 1969, British journal of experimental pathology.

[25]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[26]  T. Astrup Assay and Content of Tissue Thromboplastin in Different Organs* , 1965, Thrombosis and Haemostasis.

[27]  Lewis Jh,et al.  Effects of intravenous tissue thromboplastin in dogs: development of an anticoagulant. , 1962 .

[28]  R. Warren,et al.  Endocrine factors in the alterations of the blood coagulation mechanism following surgery. , 1957, The Journal of laboratory and clinical medicine.

[29]  J. Ransohoff,et al.  Gastrointestinal bleeding in patients with spinal cord trauma. Effects of steroids, cimetidine, and mini-dose heparin. , 1981, Journal of neurosurgery.

[30]  J. Van Der Sande,et al.  Intravascular coagulation: a common phenomenon in minor experimental head injury. , 1981, Journal of neurosurgery.

[31]  B. Bennett,et al.  The normal coagulation mechanism. , 1972, The Medical clinics of North America.

[32]  H. Kwaan Disorders of fibrinolysis. , 1972, The Medical clinics of North America.

[33]  Schneider Cl Disseminated intravascular coagulation: thrombosis versus fibrination, in clinical disease states. , 1969 .

[34]  Penick Gd,et al.  Intravascular clotting: focal and systemic. , 1964 .